New targeted drug takes on hard-to-treat breast cancers
Disease control
Not yet recruiting
This study tests a new drug called SC-101 in people with advanced breast cancer that has a specific gene change (NECTIN4). The goal is to see if the drug can shrink tumors and how safe it is. About 120 adults aged 18 to 75 with triple-negative or hormone-receptor-positive breast …
Phase: PHASE2 • Sponsor: Tianjin ConjuStar Biologics Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC